Tei index, a proposed indicator of combined ventricular systolic and diastolic function, is defined as the ratio of the sum of isovolumic contraction time (IVCT) and isovolumic relaxation time (IVRT) over the ejection time (ET). 1, 2 This index has been demonstrated to be a powerful and independent prognostic indicator in patients with various cardiac disorders. [3] [4] [5] [6] In addition, this index has been proven to be an indicator of combined left ventricular (LV) systolic and diastolic function by invasive or noninvasive methods 1, 2, 7, 8 and allow noninvasive differentiation of pseudonormal/ restrictive from normal mitral inflow patterns. 9 However, Tei index can only be obtained by echocardiography, which may preclude its application in evaluating global heart function, if echocardiography is not available. A clinical device, ABI-form (Colin VP1000, Komaki, Japan), has been developed to automatically and simultaneously measure blood pressures (BPs) in both arms and ankles and record pulse waves of the brachial and posterior tibial arteries using an automated oscillometric method. Using this device, we can easily obtain the value of brachial-ankle pulse wave velocity (baPWV). 10 In addition, this device can also automatically calculate the right brachial pre-ejection period (rbPEP) and right brachial ET (rbET) by analyzing the signals of electrocardiogram, phonocardiogram, and right brachial pressure volume waveform. Systolic time intervals were one of the established noninvasive techniques for the quantitative assessment of cardiac performance and remained valuable for clinical application. 11 In addition, Masugata et al. found that baPWV had a significant correlation with LV diastolic function. 12 Abhayaratna et al. have demonstrated that aortic PWV progressively increased according to the severity of diastolic dysfunction and had a significant correlation with early diastolic mitral annular velocity (Ea). 13 Several previous studies have also reported a relation between arterial stiffness and LV diastolic function. [14] [15] [16] We mimic the formation of Tei index, which is derived from two systolic and 
Background
Right brachial pre-ejection period (rbPEP), brachial-ankle pulse wave velocity (baPWV), and right brachial ejection time (rbET) can be automatically determined from an aBI-form device. The aims of this study are to test the applicability of baPWV-derived myocardial performance index (MPI) (defined as the ratio of rbPEP divided by its own s.d. + baPWV divided by its own s.d. to rbET divided by its own s.d.) as an indicator of combined left ventricular (LV) systolic and diastolic functions. Methods a sum of 215 patients were consecutively included. The rbPEP, baPWV, and rbET were measured using an aBI-form device and LV function was determined by echocardiography. results after a multivariate analysis, diastolic blood pressure (β = 0.220, P < 0.001), LV ejection fraction (LVEF) (β = −0.291, P < 0.001), transmitral E wave velocity (E) (β = −0.106, P = 0.032), early diastolic mitral annular velocity (Ea) (β = −0.142, P = 0.009), and ET obtained by tissue Doppler echocardiography (β = −0.397, P < 0.001) were the major determinants of baPWV-derived MPI. The area under the curve for rbPEP, baPWV, rbET, rbPEP/rbET, and baPWV-derived MPI in prediction of Ea <8 cm/s, E/ Ea >10, or LVEF <50% were 0.69, 0.76, 0.67, 0.73, and 0.83, respectively. articles baPWV-Derived MPI and Cardiac Performance one diastolic components and create a new index (defined as the ratio of rbPEP divided by its own s.d. + baPWV divided by its own s.d. to rbET divided by its own s.d.). We convert rbPEP, baPWV, and rbET to s.d. unit because of different units among them, so this index is unitless. We name it as baPWV-derived myocardial performance index (MPI). The aims of this study are to evaluate the determinants of baPWV-derived MPI and see whether it can be served as a useful parameter in evaluation of cardiac performance.
Methods
Study subjects. Study subjects were consecutively selected from the patients arranged for echocardiographic examination at Kaohsiung Municipal Hsiao-Kang Hospital. Patients with significant aortic or mitral valve disease, atrial fibrillation, and inadequate image visualization were excluded. Finally, 215 patients (124 men; age 56 ± 13 years) were included in this study. All patients were in sinus rhythm. The protocol was approved by our Institutional Review Board and all enrolled patients gave written, informed consent.
Echocardiographic assessment. The echocardiographic examination was performed by one experienced sonographer using transthoracic echocardiography (Vivid 7; General Electric Medical Systems, Horten, Norway), with the participant respiring quietly in the left decubitus position. Two-dimensional and two-dimensionally guided M-mode images were recorded from the standardized views. LV mass was calculated using Devereux-modified method. 17 LV mass index (LVMI) was calculated by dividing LV mass by body surface area. LV hypertrophy (LVH) was considered to be present when LVMI exceeded 134 g/m 2 and 110 g/m 2 for men and women, respectively. 18 The Doppler sample volume was placed at the tips of the mitral leaflets to get the LV inflow waveforms from the apical 4-chamber view. All sample volumes were positioned with ultrasonic beam alignment to flow. Tissue Doppler imaging was obtained with the sample volume placed at the lateral corner of the mitral annulus from the apical 4-chamber view. The wall filter settings were adjusted to exclude high-frequency signals and the gain was minimized. LV ejection fraction (LVEF) was measured by the modified Simpson's method. On the tissue Doppler images, IVCTa was measured from the end of diastolic mitral annular velocity pattern to the onset of the systolic mitral annular velocity pattern, ETa was measured from the onset to the end of systolic mitral annular velocity pattern, and IVRTa was measured from the end of systolic mitral annular velocity pattern to the onset of diastolic mitral annular velocity pattern. 19, 20 The raw ultrasonic data were recorded and analyzed offline by a cardiologist, blinded to the other data, using EchoPAC software (GE Medical Systems). The echocardiographic data were obtained from three consecutive beats and then the data were averaged to give the mean value for later analysis.
Assessment of baPWV, rbPEP, and rbET. Within 5 min after the completion of echocardiographic examination, baPWV, rbPEP, and rbET were assessed by using an ABI-form device, which automatically and simultaneously measures BPs in both arms and ankles using an oscillometric method. For measuring baPWV, pulse waves obtained from the brachial and tibial arteries were recorded simultaneously, and the transmission time, which was defined as the time interval between the initial increase in brachial and tibial waveforms, was determined. The transmission distance from the arm to each ankle was calculated according to body height. The value of baPWV was automatically computed as the transmission distance divided by the transmission time. After obtaining bilateral baPWV values, the average of the two values was used for analysis. Systolic and diastolic BPs were measured by the same device. The average of systolic and diastolic BPs of bilateral arms was used for analysis. The rbET was automatically measured from the foot to the dicrotic notch (equivalent to the incisura on the downstroke of the aortic pressure wave contour produced by the closure of aortic valve) of the pulse volume waveform. Total electromechanical systolic interval (QS 2 ) was measured from the onset of the QRS complex on the electrocardiogram to the first high-frequency vibrations of the aortic component of the second heart sound on the phonocardiogram. The rbPEP was also automatically calculated by subtracting the rbET from the QS 2 (Figure 1 ).
Reproducibility. Twenty-eight patients were randomly selected for evaluation of the reproducibility of rbPEP, baPWV, rbET, rbPEP/rbET, and baPWV-derived MPI by two separate measurements at least 5 min apart. Mean percent error was calculated as the absolute difference divided by the average of the two observations. articles baPWV-Derived MPI and Cardiac Performance analysis. The relationship between two continuous variables was assessed by a bivariate correlation method (Pearson's correlation). Subsequently, significantly correlated variables in the univariate analysis were further analyzed by a stepwise multiple linear regression analysis. Receiver operating characteristic curve was constructed for prediction of LVH and abnormal LV function. All tests were two-sided, and the level of significance was established as P < 0.05.
results
The baseline characteristics of 215 study patients are shown in Table 1 . There were 41 (19%) patients with LVEF <50%. There were 51 (24%) patients with LVH. There were 22 (10%) patients with old myocardial infarction, 20 (9%) patients with dilated cardiomyopathy, and 47 (22%) patients with coronary artery disease. The drugs for disease control, including β-blockers (44%), calcium channel blockers (24%), angiotensin-converting enzyme inhibitors (15%), angiotensin II antagonists (28%), and diuretics (17%), were continued without interruption. The s.d. of rbPEP, baPWV, and rbET were 17 ms, 436 cm/s, and 33 ms, respectively. Therefore, baPWV-derived MPI was equal to ((rbPEP/17) + (baPWV/436))/(rbET/33) in the study.
In a univariate analysis, rbPEP had a positive correlation with diastolic BP, LV end-diastolic volume (LVEDV), LV endsystolic volume (LVESV), LVMI, the ratio of E to transmitral A velocity (A), E/Ea, IVCTa, and IVRTa (r ≥ 0.151, P ≤ 0.018) and had a negative correlation with LVEF, A, Ea, late dia stolic mitral annular velocity (Aa), and ETa (r ≤ −0.147, P ≤ 0.031). The baPWV had a positive correlation with age, systolic and diastolic BPs, LVMI, A, E-wave deceleration time (EDT), Aa, E/Ea, IVCTa, and IVRTa (r ≥ 0.147, P ≤ 0.031); and had a negative correlation with LVEF, E, E/A, Ea, and ETa (r ≤ −0.138, P ≤ 0.043). The rbET had a positive correlation with age, LVEF, A, EDT, Ea, and ETa (r ≥ 0.161, P ≤ 0.018); and had a negative correlation with heart rate, diastolic BP, body mass index, LVEDV, LVESV, LVMI, E/A, and E/Ea (r ≤ −0.173, P ≤ 0.011). The rbPEP/rbET had a positive correlation with heart rate, diastolic BP, body mass index, LVEDV, LVESV, LVMI, E/A, E/Ea, IVCTa, and IVRTa (r ≥ 0.247, P < 0.001); and had a negative correlation with age, LVEF, A, EDT, Ea, Aa, and ETa (r ≤ −0.243, P < 0.001).
Univariate and multivariate correlates of baPWV-derived MPI are shown in Table 2 . In a univariate analysis, articles baPWV-Derived MPI and Cardiac Performance baPWV-derived MPI had a positive correlation with heart rate, systolic and diastolic BPs, body mass index, diabetes mellitus, hypertension, LVEDV, LVESV, LVMI, E/Ea, IVCTa, and IVRTa; and had a negative correlation with LVEF, E, Ea, and ETa. After a multivariate analysis, diastolic BP (β = 0.220, P < 0.001), LVEF (β = −0.291, P < 0.001), E (β = −0.106, P = 0.032), Ea (β = −0.142, P = 0.009), and ETa (β = −0.397, P < 0.001) were the major determinants of baPWV-derived MPI. Figure 2 showed the regression plots between Ea and baPWV-derived MPI and between LVEF and baPWVderived MPI. In addition, Tei index by tissue Doppler echocardiography had a significant correlation with rbPEP (r = 0.314, P < 0.001), baPWV (r = 0.242, P < 0.001), rbET (r = −0.425, P < 0.001), rbPEP/rbET (r = 0.507, P < 0.001), and baPWV-derived MPI (r = 0.551, P < 0.001).
The receiver operating characteristic curves for rbPEP, baPWV, rbET, rbPEP/rbET, and baPWV-derived MPI in prediction of Ea <8 cm/s, E/Ea >10, or LVEF <50% are shown in Figure 3 . The area under the curve (AUC) for rbPEP, baPWV, rbET, rbPEP/rbET, and baPWV-derived MPI in prediction of LVH, Ea <8 cm/s, E/Ea >10, Ea <8 cm/s or E/Ea >10, LVEF <50%, and Ea <8 cm/s, E/Ea >10, or LVEF <50% are shown in Table 3 . The statistical values of rbPEP >102 ms, baPWV >1,620 cm/s, rbET <283 ms, rbPEP/rbET >0.36, and baPWV-derived MPI >1.10 in prediction of Ea <8 cm/s, E/ Ea >10, or LVEF <50% are shown in Table 4 .
reproducibility
The mean percent errors for rbPEP, baPWV, rbET, rbPEP/ rbET, and baPWV-derived MPI were 3.6 ± 3.6, 3.3 ± 3.4, 2.0 ± 1.5, 4.2 ± 4.4, and 2.9 ± 2.2%, respectively.
discussion
This study demonstrated that baPWV-derived MPI had a significant correlation with echocardiographic LV diastolic and systolic function. This index may be a promising and feasible marker in evaluation of global LV function. Although echocardiography can be successfully used in community screening, it is still expensive, operator-dependent, time-consuming, and not affordable in all communities. BaPWV-derived MPI automatically obtained from an ABI-form device may be helpful for large-volume screening. The prolongation of PEP may be caused by a diminished rate of LV pressure rise during isovolumic contraction. 11 Increased PEP usually occurred when heart function decreased. 21 In the present study, rbPEP had a significant correlation with IVCTa and LVEF in a univariate analysis. This may suggest that rbPEP is also a useful parameter in the evaluation of LV systolic function. Thus, it can be served as a systolic component of baPWVderived MPI.
Many previous studies have reported a relation between arterial stiffness and LV diastolic function. [12] [13] [14] [15] [16] Abhayaratna et al. have demonstrated that aortic PWV had a significant correlation with Ea. 13 In this study, baPWV also had a significant correlation with Ea, which was consistent with Abhayaratna's finding. In addition, baPWV was also significantly associated with IVRTa and E/Ea in this study. This implies baPWV may have a correlation with LV diastolic function. Thus, it can be served as the diastolic component of baPWV-derived MPI.
The duration of ET reflects both the velocity and extent of fiber shortening. In LV decompensation, the extent of fiber shortening is decreased, so a shortened ET is usually noted. 22 In this study, rbET had a significant correlation with ETa and LVEF, so it could be used as another systolic component of baPWV-derived MPI. However, because heart rate had a significantly negative correlation with rbET, the value of rbET could be influenced by heart rate alteration.
Because heart function impairment usually prolongs PEP and shortens ET, the ratio of PEP to ET may enhance the diagnostic value for identification of LV dysfunction. A high correlation (r = −0.90) between PEP/ET and LVEF has been shown in patients with a wide variety of heart disease. 22 In the present study, rbPEP/rbET had a significant correlation with LVEF in a univariate analysis. Thus, rbPEP/rbET was also a useful index in evaluation of LV systolic function.
In the present study, because decreased LV function had a significant correlation with prolonged rbPEP, increased baPWV, and shortened rbET, baPWV-derived MPI should have a good correlation with LV systolic and diastolic function. In fact, baPWV-derived MPI had a significant correlation with LVEF and Ea after a multivariate analysis.
Many studies have shown heart rate has no correlation with Tei index. 1, 2, 19, 20 Similarly, heart rate was only correlated with rbET, but not correlated with rbPEP and baPWV, so heart rate was not a significant determinant of baPWV-derived MPI after a multivariate analysis. Therefore, heart rate may also not have a major impact on baPWV-derived MPI. In addition, previous studies have demonstrated that BP is not a determinant of Tei index. 1, 2, 19 In the present study, systolic BP was only correlated with baPWV, but not correlated with rbPEP and rbET, so systolic BP was also not a significant determinant of baPWV-derived MPI after a multivariate analysis. However, diastolic BP had a positive correlation with rbPEP and baPWV but a negative correlation with rbET, so it was a significant determinant of baPWV-derived MPI after a multivariate analysis. Therefore, the diastolic BP could influence the valve of baPWV-derived MPI in the present study.
The Ea <8 cm/s or E/Ea >10 were reported to be a useful indicator of LV diastolic dysfunction. [23] [24] [25] [26] [27] [28] Compared with the other parameters, baPWV-derived MPI had a relatively high AUC in prediction of Ea <8 cm/s or E/Ea >10. Thus, baPWV-derived MPI may be a relatively good parameter in assessment of LV diastolic function. Both rbPEP/rbET and baPWV-derived MPI had a relatively high AUC in prediction of LVEF <50%. Therefore, these two parameters may be relatively useful in evaluation of LV systolic function. In addition, the AUC of baPWV-derived MPI in prediction of Ea <8 cm/s, E/Ea >10, or LVEF <50% was relatively high, so baPWVderived MPI seemed to be relatively good in identification of patients with Ea <8 cm/s, E/Ea >10, or LVEF <50% among these parameters.
This study has several limitations. The majority of our patients were treated chronically with antihypertensive medications. For ethical reasons, we did not withdraw the medications. Hence, we could not exclude the influence of antihypertensive agents on the present findings. We only evaluated the correlation between baPWV-derived MPI and its components with noninvasive echocardiographic parameters of LV systolic and diastolic function. We did not further validate our finding with invasive methodology. In addition, we do not follow-up our study patients, so we cannot determine whether baPWV-derived MPI is a useful index in the prediction of cardiovascular events. Further prospective study is needed to address this issue. baPWV, brachial-ankle pulse wave velocity; E, peak early transmitral filling wave velocity; Ea, early diastolic velocity of lateral mitral annulus; LVEF, left ventricular ejection fraction; MPI, myocardial performance index; rbET, right brachial ejection time; rbPEP, right brachial pre-ejection period.
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In conclusion, baPWV-derived MPI may be a novel, feasible, and useful indicator in the assessment of global LV function. It may be helpful in identification of patients with Ea <8 cm/s, E/ Ea >10, or LVEF <50%.
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